Latest News

EBOS Group (NZSE:EBO) just opened its new Symbion pharmacy wholesale distribution centre in Kemps Creek, Sydney. This marks a big step forward in the company's four-year, $360 million facility renewal program. This new centre focuses on automation, efficiency, and future growth potential. See our latest analysis for EBOS Group. After a tough year that saw EBOS Group log a one-year total shareholder return of -18.7% and a year-to-date share price decline of 24.2%, momentum has softened even as...

EDU Holdings Limited ( ASX:EDU ) shares have retraced a considerable 28% in the last month, reversing a fair amount of...

Redox (ASX:RDX) has had a great run on the share market with its stock up by a significant 17% over the last three...

Tian An Australia Limited ( ASX:TIA ) shares have continued their recent momentum with a 32% gain in the last month...

There wouldn't be many who think Nuchev Limited's ( ASX:NUC ) price-to-sales (or "P/S") ratio of 1.1x is worth a...

Ever wondered if Innoviva might be hiding some real value, or if it is just another biotech stock flying under the radar? You are not alone. Let’s dive in and see what sets it apart right now. Innoviva's stock has climbed 3.8% in the past week and 4.8% year-to-date, though it is still down 8.5% over the last year. This shows both recent momentum and a hint of volatility. Investors took notice as Innoviva finalized its acquisition of a smaller biotech firm, adding promising drug candidates to...

AMG Critical Materials (ENXTAM:AMG) posted a strong set of headline numbers, with earnings forecast to grow 39.9% per year, well ahead of the Dutch market’s 11.2% growth rate. Revenue, meanwhile, is expected to rise 4.7% annually, trailing the broader market’s 7.8%. The company has recently returned to profitability and has grown earnings by 7.4% per year over the past five years.

Select Water Solutions (WTTR) has posted five years of profitable growth, with annual earnings increasing an impressive 75.6% during that stretch. However, the company’s latest results show a net profit margin of 2.3%, down from 3.9% last year. Revenue is forecast to grow at just 1.3% per year, in comparison to the US market’s 10.5%. Shares currently trade at $11.48, well below the discounted cash flow fair value estimate of $19.55. The price-to-earnings ratio sits at a premium 36.2x versus...

Patria Investments (PAX) reported a net profit margin of 21.2%, down from last year’s 26%, and earnings growth of 3.2% in the latest year, despite a flat longer-term track record. The consensus expects profit to expand by 30.5% annually over the next three years, while revenue is forecast to grow at 13.5% per year, outpacing the US market average of 10.5%. Shares currently trade above estimated fair value at $15.2 versus $10.9, and a hefty Price-to-Earnings ratio of 28.8x points to a lot of...

Organon & Co. ( NYSE:OGN ) shareholders won't be pleased to see that the share price has had a very rough month...

First Majestic Silver (TSX:AG) has swung into profitability, reversing a period of losses and signaling a clear shift in its earnings profile. Over the past year, the company improved its net profit margin and is now projected to grow earnings at 32.3% per year, outpacing both its historical performance and industry expectations. Revenue is forecast to increase at 16.3% annually, which stands above the broader Canadian market average. With high-quality earnings and a trading price below...

Ever wondered if Atlas Energy Solutions stock is a bargain or just another name in the headlines? If you are curious about value—not just price—this could be the stock to watch. This year, shares have dropped a steep 51.1%, with a 7-day slide of 6.9% and a 30-day loss of 5.5%. These movements hint at both changing risk perceptions and possible opportunity for bold investors. Market chatter has focused on shifting industry dynamics, with headlines highlighting Atlas Energy Solutions’...

ASKA Pharmaceutical Holdings (TSE:4886) posted a net profit margin of 7.1% for the latest period, down from 9.4% a year earlier, while also recording a one-off gain of ¥1.2 billion ahead of September 2025. Over the last five years, earnings grew at an average rate of 18% annually. However, the most recent year saw a decline, and both earnings and revenue are now forecast to rise at a more modest 2.9% per year, lagging the broader Japanese market’s growth expectations. With a current...

Shoals Technologies Group (SHLS) posted earnings growth of 1.2% over the past year, falling short of its five-year average of 7.1% per year. Looking ahead, analysts expect Shoals’ earnings to grow at an impressive 26.4% per year, with revenue forecasts indicating an 11% annual rise. Both figures are slightly ahead of the broader US market. The company currently maintains a 7.7% profit margin, just under last year’s 7.8%, giving investors a picture of steady, if modest, profitability as the...

TWFG (TWFG) shares ticked up almost 3% over the past week, catching investor attention following a recent shift in the insurance sector. The company’s latest financials highlight annual revenue growth of 17% along with robust net income improvement. See our latest analysis for TWFG. TWFG’s recent 2.98% 7-day share price return stands out against a challenging year for holders, with a 1-year total shareholder return of -25.67%. Momentum appears to be picking up following sector optimism and...

Power Integrations (POWI) just reported revenue growth forecasts of 12.4% per year, surpassing the US market average of 10.5%. Investors will note that net profit margin has dropped to 7.6% from last year’s 10.4%. While revenue projections are strong, the company has faced negative earnings growth over the past year and a five-year earnings decline of 28% per year. With a price-to-earnings ratio of 66.1x, well above the industry and peer averages, and a current share price of $39.59, above...

Gestamp Automoción (BME:GEST) reported a net profit margin of 1.4%, slightly below last year’s 1.5%, following a year of negative earnings growth despite averaging a robust 25.2% annual improvement in profitability over the past five years. The stock currently trades at €2.87, which is well below its estimated fair value of €5.84. A price-to-earnings ratio of 9.8x sets it apart as attractively valued compared to industry benchmarks. Looking ahead, investors will be watching the company’s...

NCR Voyix Corporation recently reported third quarter 2025 earnings, revealing revenue of US$684 million and a net loss of US$19 million, both lower than the previous year, alongside updated full-year revenue guidance of US$2.65 billion to US$2.67 billion. One unusual detail is the significant swing from net income in the prior year to a net loss this quarter, underscoring the impact of shifting market conditions and operational changes on NCR Voyix’s financial results. With NCR Voyix...

EQL Pharma (OM:EQL) is projecting standout rates, with earnings forecast to climb 59.57% per year and revenue expected to grow 30.4% annually, far outpacing the Swedish market’s 3.7% revenue growth outlook. Over the past five years, the company saw earnings rise by 19.1% each year and currently holds a net profit margin of 7.4%, down from last year’s 9.9%. With a Price-to-Earnings ratio of 54.3x, EQL trades above the broader European healthcare sector but remains slightly below its immediate...

When companies post strong earnings, the stock generally performs well, just like Sun Country Airlines Holdings, Inc.'s...

Amidst the current market volatility and geopolitical uncertainties, Australia's stock market has been experiencing fluctuations, with inflation concerns and sector-specific performances shaping investor sentiment. In this environment, identifying growth companies with high insider ownership can be an attractive strategy as it often indicates strong confidence from those closest to the business, potentially aligning well with investors seeking stability and potential long-term value.

The board of Rockwell Automation, Inc. ( NYSE:ROK ) has announced that the dividend on 10th of December will be...

The Australian stock market has been navigating through a period of uncertainty, with indices fluctuating due to geopolitical events and rising inflation, leaving investors cautious yet hopeful as they seek stability. In such volatile conditions, identifying stocks that may be trading below their estimated value can offer potential opportunities for those looking to capitalize on market inefficiencies.

Arm Holdings (ARM) posted a net profit margin of 18.8%, improving from 18.1% a year earlier, as earnings surged 29.5% in the latest period. This increase is well ahead of its five-year compound annual growth rate of 11.3%. Earnings are forecast to grow another 29% annually in the future, and revenue is expected to climb by 18.3% per year, both well above US market averages. While high quality earnings and robust profit growth are clear rewards for investors, the stock's $160.19 share price is...